суббота, 3 марта 2012 г.

EUSA Pharma, a transatlantic speciality pharmaceutical company, has acquired US-based oncology and pain control specialist Cytogen for an estimated $50m.(Business Digest)(Brief article)

EUSA Pharma, a transatlantic speciality pharmaceutical company, has acquired US-based oncology and pain control specialist Cytogen …

Комментариев нет:

Отправить комментарий